China's healthcare industry set for foreign investment explosion
This article was originally published in Scrip
Executive Summary
Foreign Direct Investment (FDI) into China's life sciences sector will increase by 177% to £128.2bn by 2020, as the rapidly ageing population drives demand for healthcare services and the Chinese government makes efforts to relax controls. So says a new report from global law firm King & Wood Mallesons, Branching Out: Investment Opportunities in China in 2020.